• Phosbind Acrylamide: Practical Phosphorylation Workflows

  2026-08-23

  Phosbind Acrylamide enables antibody-free, gel-based comparison of phosphorylated and non-phosphorylated proteins, making it useful for kinase assays, signaling screens, and multisite mutant studies. Its mobility-shift workflow complements functional readouts by showing whether phosphorylation changes are reflected in the electrophoretic behavior of the target.

• Berberrubine chloride: Applied Research Workflows

  2026-08-22

  Berberrubine chloride supports mechanism-led colorectal cancer research, NSCLC chemosensitivity studies, redox assays, and urate biology. This workflow guide connects concentration selection, IMPDH2 validation, orthogonal readouts, and troubleshooting for more reproducible preclinical experiments.

• Reactive Oxygen Species Assay Kit (DHE) Workflow

  2026-08-22

  Build a reproducible live-cell superoxide workflow with practical controls, plate-reading guidance, and troubleshooting strategies. The assay is especially useful for connecting oxidative stress measurements with apoptosis research, TrxR/MAPK biology, and tumor-immunity experiments.

• ML365: TASK1 Inhibition in Applied Research

  2026-08-21

  ML365 combines nanomolar TASK1 potency with strong channel selectivity, making it useful for electrophysiology, target validation, and membrane-excitability studies. Its emerging connection to hippocampal NLRP3 signaling also supports carefully controlled neuroinflammation workflows, provided concentration-dependent mGluR5 activity is addressed.

• MST1/2 Integrate Macrophage Death Signals

  2026-08-20

  The 2025 JBC study identifies MST1/2 cleavage as a flexible apoptotic signaling node that integrates sterile inflammatory stimuli with pathogen-specific macrophage responses. Its comparison of inflammasome, GSDMD, caspase, and bacterial infection conditions clarifies why macrophages can switch between apoptosis and pyroptosis.

• DAPI Workflows for PAD4-NETs Research

  2026-08-20

  Build sharper nuclear imaging, apoptosis, and membrane-integrity assays around DAPI in tumor–neutrophil models. This workflow connects microscopy and flow cytometry to the PAD4–H3cit–NETs mechanism while clearly separating nuclear morphology from definitive pathway or viability measurements.

• CD38 CAR Binder Structures and Rational Affinity Tuning

  2026-08-19

  This pre-proof iScience study structurally compares the CD38 binders RP02 and 028, showing that they recognize distinct epitopes and differ in their effects on CD38 enzymatic activity. Its affinity-tuned 028R103G CAR reduced fratricide while retaining antitumor cytotoxicity, illustrating how structural information can guide safer CD38 CAR design.

• CCR7–Notch1 Crosstalk Promotes Mammary Cancer Stemness

  2026-08-19

  Boyle et al. identified a functional connection between CCR7 and Notch1 signaling in primary MMTV-PyMT mammary tumor cells, showing that CCR7 activity promotes Notch activation and stem-like behavior. The reciprocal inhibition experiments provide a mechanistic framework for studying mammary cancer stemness, while also highlighting the need for carefully controlled molecular assays.

• SU6656 Src tyrosine kinases inhibitor guide

  2026-08-18

  SU6656 offers a practical way to probe Src-dependent megakaryocyte maturation, platelet release, and tumor-endothelial responses. This guide separates validated evidence from pilot recommendations for hiPSC platelet workflows, radiotherapy studies, and cancer research.

• Lypressin Acetate: From Mechanism to Translation

  2026-08-18

  A translational framework for using Lypressin acetate to connect vasopressin receptor biology, endocrine modeling, vasoconstriction research, assay design, and carefully bounded antiviral exploration.

• JNJ-26481585: From HDAC Inhibition to TRIM21

  2026-08-17

  Explore how JNJ-26481585 (Quisinostat) connects chromatin acetylation with TRIM21–ERK1/2 signaling in pituitary adenoma research. This article translates the reference study into a more rigorous framework for apoptosis, proliferation, and drug-sensitivity assays.

• Mdivi-1: Reading DRP1 Signaling in Hypoxia

  2026-08-17

  Mdivi-1 is a selective DRP1 inhibitor that can reveal how mitochondrial fission intersects with hypoxia-driven cell communication. This article presents a donor–recipient assay framework grounded in the SP1/ADAM10/DRP1 study and distinguishes pathway placement from simple mitochondrial fragmentation.

• Pollen Interference in EEM Bioaerosol Classification

  2026-08-16

  A 2024 Molecules study showed that pollen can distort fluorescence-based classification of hazardous biological materials, but spectral preprocessing and fast Fourier transform analysis substantially improved discrimination. The resulting random-forest workflow reached 89.24% accuracy and offers a practical framework for reducing environmental interference in rapid bioaerosol screening.

• L-Alanyl-L-Glutamine: Practical Lab Workflow

  2026-08-15

  L-Alanyl-L-Glutamine provides a water-soluble L-Ala-L-Gln dipeptide format for controlled nutritional and gastrointestinal barrier experiments. It is suitable for aqueous formulation and enteral or intestinal model workflows, but dossier-described benefits should not be treated as proof of efficacy in a specific disease, cell system, or clinical application without matched evidence.

• GKT137831: Redox Control Meets Ferroptosis

  2026-08-14

  GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor for separating ROS initiation from ferroptotic membrane failure. This guide translates redox biology and lipid-scrambling research into practical assay decisions.

580 records 9/39 page Previous Next First page 上5页 678910 下5页 Last page